The actual controller of REMEGEN (688331.SH) completed the acquisition of 369,200 shares through the controlled enterprise.
Rongchang Biology (688331.SH) announced that from July 9, 2024 to January 8, 2025, the company...
REMEGEN (688331.SH) announced that from July 9, 2024 to January 8, 2025, the actual controllers of the company, including Wang Weidong, Fang Jianmin, Lin Jian, Wang Liqiang, Wang Xudong, Deng Yong, Xiong Xiaobin, Yang Minhua, Wen Qingkai, and Wei Jianliang, through their controlled enterprise Yantai Rongchang Holdings Group Co., Ltd., increased their holdings of the company's shares by a total of 369,200 shares through the Shanghai Stock Exchange trading system through centralized competitive bidding, accounting for 0.0678% of the company's total share capital, with a total increase amount of RMB 10,000,000.646 (excluding transaction costs), which has exceeded the lower limit of the current shareholding increase plan. The shareholding increase plan has been completed.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


